Aditya Birla Sun Life Pharma & Healthcare Fund
The fund maintains heavy conviction in large-cap pharma dominance, with Sun Pharma anchoring over a third of assets and the top five names representing nearly 35 percent of the portfolio. The concentrated 77 percent pharma allocation reflects a classic defensive positioning around domestic generics and export-driven stories, while the modest healthcare services exposure provides modest diversification within the thematic. The addition of Dr. Lal Path Labs and trimming of IPCA signals the manager's preference for diagnostics upside over mid-tier generic makers facing margin pressures.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Regular Growth | ₹32.7900 | +7.51% | +7.54% | +4.43% | +10.85% | +23.97% | +12.77% |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Dr. Lal Path Labs Limited | 0.94% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 13.17% |
| 2 | Apollo Hospitals Enterprise Limited INE437A01024 | 7.20% |
| 3 | Torrent Pharmaceuticals Limited INE685A01028 | 4.76% |
| 4 | J.B. Chemicals & Pharmaceuticals Limited INE572A01036 | 4.71% |
| 5 | Aurobindo Pharma Limited INE406A01037 | 4.49% |
| 6 | Ajanta Pharmaceuticals Limited INE031B01049 | 4.05% |
| 7 | Lupin Limited INE326A01037 | 4.00% |
| 8 | Mankind Pharma Ltd INE634S01028 | 3.88% |
| 9 | Fortis Healthcare Limited INE061F01013 | 3.87% |
| 10 | Abbott India Limited INE358A01014 | 3.65% |
| 11 | Emcure Pharmaceuticals Ltd INE168P01015 | 3.32% |
| 12 | Cipla Limited INE059A01026 | 3.30% |
| 13 | IPCA Laboratories Limited INE571A01038 | 2.86% |
| 14 | Shilpa Medicare Ltd INE790G01031 | 2.51% |
| 15 | CORONA Remedies Ltd INE02ZQ01018 | 2.24% |
| 16 | SAI Life Sciences Ltd INE570L01029 | 2.20% |
| 17 | Alkem Laboratories Limited INE540L01014 | 2.10% |
| 18 | Procter & Gamble Health Limited INE199A01012 | 2.04% |
| 19 | Divi's Laboratories Limited INE361B01024 | 1.88% |
| 20 | Jupiter Life Line Hospitals Ltd INE682M01012 | 1.79% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.